Literature DB >> 16675894

Yield of sputum microbiological examination in patients hospitalized for exacerbations of chronic obstructive pulmonary disease with purulent sputum.

N Roche1, B Kouassi, A Rabbat, A Mounedji, C Lorut, G Huchon.   

Abstract

BACKGROUND: Whether sputum microbiological examination should be performed systematically in hospitalized patients with chronic obstructive pulmonary disease (COPD) exacerbations remains unclear.
OBJECTIVES: To assess the yield of sputum microbiological examination in COPD patients hospitalized in a medical ward for an acute exacerbation with purulent sputum.
METHODS: Two hundred consecutive exacerbations in 118 patients were studied. Patients underwent sputum microbiological examination on admission and baseline lung function tests and CT scans were recorded. Factors associated with positive culture were analyzed.
RESULTS: Sputum culture was positive (>or=10(7) CFU/ml) in 59% of samples, Haemophilus influenzae and Streptococcus pneumoniae being the most frequent pathogens. Factors associated with positive culture were bronchiectasis, long-term oxygen therapy and low FEV1. Pseudomonas spp. were found in 8.5% of all patients, who all had a FEV1<50% of predicted and were older. Only 25% of sputum samples satisfied all quality criteria. Sputum culture was positive in a high proportion of these samples (80.5%), but also in one half of samples with >25 leukocytes but >10 epithelial cells per field. Microbiological results induced a change in antibiotic therapy in 43.9% of cases with both quality criteria but also in 25.2% of cases with only one quality criterion. Finally, a predominant aspect after Gram stain was found in all positive samples.
CONCLUSIONS: These data suggest that sputum microbiological examination with direct examination and leukocyte count should be performed routinely in patients hospitalized for COPD exacerbations with purulent sputum, especially when FEV1 is less than 50% predicted and in patients with bronchiectasis. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16675894     DOI: 10.1159/000093158

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  11 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  Profile of bacterial pneumonia during Hajj.

Authors:  Atif H Asghar; Ahmad M Ashshi; Esam I Azhar; Syed Z Bukhari; Tariq A Zafar; Aiman M Momenah
Journal:  Indian J Med Res       Date:  2011-05       Impact factor: 2.375

Review 3.  Clinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysis.

Authors:  Yingmeng Ni; Guochao Shi; Youchao Yu; Jimin Hao; Tiantian Chen; Huihui Song
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-07-28

4.  Antibiotic Prescription for COPD Exacerbations Admitted to Hospital: European COPD Audit.

Authors:  Jose Luis López-Campos; Sylvia Hartl; Francisco Pozo-Rodriguez; C Michael Roberts
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

5.  Relationship between the GOLD combined COPD assessment staging system and bacterial isolation.

Authors:  Yusuf Aydemir; Özlem Aydemir; Fatma Kalem
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-09-27

Review 6.  Bronchiectasis in COPD patients: more than a comorbidity?

Authors:  Miguel Angel Martinez-Garcia; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-05-11

7.  Markers of lower respiratory tract infections in emergency departments.

Authors:  Dursun Tatar; Gunes Senol; Ceyda Anar; Gultekin Tibet
Journal:  Multidiscip Respir Med       Date:  2013-03-15

Review 8.  Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.

Authors:  Qingxia Du; Jianmin Jin; Xiaofang Liu; Yongchang Sun
Journal:  PLoS One       Date:  2016-03-15       Impact factor: 3.240

9.  Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD.

Authors:  Ramon Boixeda; Pere Almagro; Jesús Díez-Manglano; Francisco Javier Cabrera; Jesús Recio; Isabel Martin-Garrido; Joan B Soriano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-12-01

10.  Quantitative computed tomography features and clinical manifestations associated with the extent of bronchiectasis in patients with moderate-to-severe COPD.

Authors:  So Hyeon Bak; Soohyun Kim; Yoonki Hong; Jeongwon Heo; Myoung-Nam Lim; Woo Jin Kim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.